Reviewing Studies
Older age or a higher rate of comorbidities with age do not affect survival in metastatic colorectal cancer when patients receive radiofrequency ablation (RFA), high-dose-rate brachytherapy (HDR-BT), or Y90-radioembolization (Y90-RE), according to a study published in BMC Cancer. An institutional… Read More
The mutational status and histopathologic grade of patients with chemorefractory colorectal liver metastases (CRLM) may predict survival after Y90 radioembolization therapy, according to a study published in Oncotarget. Patients with wild-type mutation status along with a well-differentiated tumor… Read More
HCC liver
Using 3D voxel-based dosimetry in patients with hepatocellular carcinoma (HCC) treated by yttrium-90 (90Y) resin microspheres radioembolization, a new study determined that complete  tumor targeting and 90Y dose to tumor are independent factors associated with clinical outcomes. The results were… Read More
Reviewing Studies
Yttrium-90 (90Y) transarterial radioembolization (TARE) around immunotherapy is safe and effective and the combined treatment may improve hepatic progression-free survival (hPFS) and overall survival (OS) in patients with hepatic metastases from uveal melanoma (UM), according to a new study… Read More
tumore cells
In an exploratory case of a patient with metastatic colorectal cancer, a hotspot panel of cancer-associated gene mutations was used to identify tumor-specific mutations. The results, which showed that liquid biopsies can reveal tumor heterogeneity and predict tumor progression, were published in… Read More
HCC cells
Tumor response can be predicted after Yttrium-90 (90Y) radioembolization in patients with hepatocellular carcinoma (HCC) by analyzing the delivered tumoral radiation dose by internal pair-production positron emission tomography (PET) dosimetry, according to a study published in the International… Read More
Tumor Cells
A recent study found that PI3K pathway mutations in patients with metastatic breast cancer are associated with early imaging response after radioembolization, which is associated with  prolonged survival. The results were published in the Journal of Vascular and Interventional Radiology. This… Read More
A new study found no significant difference in overall survival (OS) for patients with early-stage non–small cell lung cancer (NSCLC) treated with either radiofrequency (RF) ablation or stereotactic body radiotherapy (SBRT). The study was published by the Journal of Vascular and Interventional… Read More
Patients with small renal masses (SRMs) who are poor candidates for nephron-sparing surgery (NSS) may benefit from radiofrequency ablation (RFA) performed percutaneously, according to a new study published in Videosurgery and Other Miniinvasive Techniques. A retrospective analysis of medical… Read More
Biopsy results of renal masses rarely obviated the need for subsequent ablation and can safely be performed alongside image-guided tumor ablation (IGTA), according to a study published in the Journal of Vascular and Interventional Radiology. A retrospective review of one institution's database… Read More